These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 16219800)
1. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Cooper N; Rao K; Gilmour K; Hadad L; Adams S; Cale C; Davies G; Webb D; Veys P; Amrolia P Blood; 2006 Feb; 107(3):1233-6. PubMed ID: 16219800 [TBL] [Abstract][Full Text] [Related]
2. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Cooper N; Rao K; Goulden N; Webb D; Amrolia P; Veys P Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S47-50. PubMed ID: 18978744 [TBL] [Abstract][Full Text] [Related]
3. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience. Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558 [TBL] [Abstract][Full Text] [Related]
4. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis. Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187 [TBL] [Abstract][Full Text] [Related]
5. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Marsh RA; Vaughn G; Kim MO; Li D; Jodele S; Joshi S; Mehta PA; Davies SM; Jordan MB; Bleesing JJ; Filipovich AH Blood; 2010 Dec; 116(26):5824-31. PubMed ID: 20855862 [TBL] [Abstract][Full Text] [Related]
6. [The clinical characteristics of adult hemophagocytic lymphohistiocytosis treated with haploidentical donor hematopoietic stem cell transplantation]. Fu L; Wei N; Wang JS; Wu L; Wang YN; Huang DY; Liu JL; Wang Z Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):273-278. PubMed ID: 28355720 [No Abstract] [Full Text] [Related]
7. Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1. Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH Biol Blood Marrow Transplant; 2014 Oct; 20(10):1641-5. PubMed ID: 24923536 [TBL] [Abstract][Full Text] [Related]
8. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis. Nishi M; Nishimura R; Suzuki N; Sawada A; Okamura T; Fujita N; Kanai R; Yano J; Adachi S; Yasumi T; Sato E; Yasutomo K; Ishii E; Ohga S Am J Hematol; 2012 Jun; 87(6):637-9. PubMed ID: 22488407 [TBL] [Abstract][Full Text] [Related]
9. Fludarabine/Melphalan 100 mg/m Park HS; Lee JH; Lee JH; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Lee KH Biol Blood Marrow Transplant; 2019 Jun; 25(6):1116-1121. PubMed ID: 30508593 [TBL] [Abstract][Full Text] [Related]
10. An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Marsh RA; Kim MO; Liu C; Bellman D; Hart L; Grimley M; Kumar A; Jodele S; Myers KC; Chandra S; Leemhuis T; Mehta PA; Bleesing JJ; Davies SM; Jordan MB; Filipovich AH Biol Blood Marrow Transplant; 2013 Nov; 19(11):1625-31. PubMed ID: 24035782 [TBL] [Abstract][Full Text] [Related]
11. Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis. Cesaro S; Gazzola MV; Marson P; Calore E; Caenazzo L; Destro R; De Silvestro G; Varotto S; Pillon M; Zanesco L; Messina C Am J Hematol; 2003 Feb; 72(2):143-6. PubMed ID: 12555220 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan. Sawada A; Ohga S; Ishii E; Inoue M; Okada K; Inagaki J; Goto H; Suzuki N; Koike K; Atsuta Y; Suzuki R; Yabe H; Kawa K; Kato K; Yasutomo K Int J Hematol; 2013 Aug; 98(2):223-30. PubMed ID: 23843148 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases. Haines HL; Bleesing JJ; Davies SM; Hornung L; Jordan MB; Marsh RA; Filipovich AH Biol Blood Marrow Transplant; 2015 Feb; 21(2):288-92. PubMed ID: 25464116 [TBL] [Abstract][Full Text] [Related]
14. Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis. Lehmberg K; Albert MH; Beier R; Beutel K; Gruhn B; Kröger N; Meisel R; Schulz A; Stachel D; Woessmann W; Janka G; Müller I Haematologica; 2014 Jan; 99(1):180-4. PubMed ID: 24162790 [TBL] [Abstract][Full Text] [Related]
15. A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. Shore T; Harpel J; Schuster MW; Roboz GJ; Leonard JP; Coleman M; Feldman EJ; Silver RT Biol Blood Marrow Transplant; 2006 Aug; 12(8):868-75. PubMed ID: 16864057 [TBL] [Abstract][Full Text] [Related]
16. Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen. Gonzalez-Llano O; Jaime-Pérez J; Cantu-Rodríguez O; Mancias-Guerra C; Gutierrez-Aguirre H; Herrera-Garza J; Gomez-Almaguer D Eur J Haematol; 2006 Oct; 77(4):341-4. PubMed ID: 16856932 [TBL] [Abstract][Full Text] [Related]
17. Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission. Eom KS; Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Park CW; Lee S Am J Hematol; 2013 Aug; 88(8):634-41. PubMed ID: 23620000 [TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis. Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970 [TBL] [Abstract][Full Text] [Related]
19. Age Impacts Risk of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Non-Severe Combined Immune Deficiency Inborn Errors of Immunity. Fitch T; Lane A; McDonnell J; Bleesing J; Jordan M; Kumar A; Khandelwal P; Khoury R; Marsh R; Chandra S Transplant Cell Ther; 2024 Jan; 30(1):101.e1-101.e12. PubMed ID: 37821080 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis. Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]